Concepedia

Publication | Closed Access

A randomized, double‐blind, placebo‐controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis

DOI

223

Citations

18

References

2013

Year

James F. Howard, Richard J. Barohn, Gary Cutter, Miriam Freimer, Vern C. Juel, Tahseen Mozaffar, Michelle Mellion, Michael Benatar, Maria Elena Farrugia, Jing Jing Wang,
Muscle & Nerve

Abstract

The data suggest that eculizumab may have a role in treating severe, refractory MG.

References

YearCitations

Page 1